Overview of the risk factors, prevention and management of SARS-COV-2
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2020.
第一著者: | Mustafa, Nashrah |
---|---|
その他の著者: | Hossain, Mahboob |
フォーマット: | 学位論文 |
言語: | en_US |
出版事項: |
Brac University
2021
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/14501 |
類似資料
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
著者:: Iva, Yesmine Akter
出版事項: (2022) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
著者:: Sarwar, Subyeta Binte
出版事項: (2024) -
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
著者:: Intesar, Mohammad Nafees
出版事項: (2023) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
著者:: Bosu, Sagar
出版事項: (2023) -
Wave-wise comparison of COVID 19 based on SARS-CoV-2 Variants of Concern (VOCs) in Bangladesh, India, Sri Lanka, Pakistan, Nepal and the probable reasons behind the less devastating effects of Delta variant in Bangladesh: a review
著者:: Hasan, Mahfuzul, 等
出版事項: (2022)